Acadian Asset Management
DMK

Acadian Asset Management’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Acadian Asset Management’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,107
Closed -$42K – 2407
2020
Q2 		$42K Buy
1,107
+1,071
+2,975% +$36.6K ﹤0.01% 1967
2020
Q1 		$1K Sell
36
-366
-91% -$15.5K ﹤0.01% 1770
2019
Q4 		$20K Buy
+402
New +$19.5K ﹤0.01% 1724

Other funds holding DMK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCA
Verdence Capital Advisors Hunt Valley, Maryland $1.72B AUM 24.88% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Acadian Asset Management's DMK Position: Q3 2020 in Review

Acadian Asset Management sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q3 2020, closing a stake of 1,107 shares — an estimated $42K sold.

Acadian Asset Management first reported a position in DMK in Q4 2019 and held it in 3 quarters. The position peaked at $42K in Q2 2020. 46 funds tracked by Wall St. Rank hold DMK as of Q3 2020.

  • Acadian Asset Management reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q3 2020 after selling out during the quarter.
  • Acadian Asset Management sold 1,107 DMK Pharmaceuticals Corporation Common Stock shares in Q3 2020, an estimated $42K.
  • Acadian Asset Management first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2019 and held it in 3 quarters.
  • Acadian Asset Management's DMK Pharmaceuticals Corporation Common Stock position peaked at $42K in Q2 2020.
  • 46 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q3 2020.

Based on Acadian Asset Management's 13F filing for Q3 2020, filed 9 Nov 2020.